Laryngeal carcinoma in females.
Between 1950 and 1992, 96 women with squamous cell carcinoma of the larynx were diagnosed and treated in the Department of Otolaryngology and Oncology at Beilinson Medical Center, Israel, and Long Island College Hospital, Brooklyn, New York. Fifty-seven female patients (59%) had glottic carcinoma, 72% of them in stage I. Thirty-eight had supraglottic carcinoma, 68% of them in stages II and III. One patient had stage I subglottic carcinoma. Treatment varied between radiotherapy, surgery, or combined surgery with radiation and/or chemotherapy. The 5-year survival rate was 87%. Although most of the patients had glottic carcinoma in stage I, there was also a high percentage with supraglottic carcinoma, most in advanced stages and with metastases to other regions. The prognosis is not different from that in men. Smoking is an important factor in glottic carcinoma, but not as important as in males.
Shvero
J
J
Department of Otolaryngology and Head and Neck Surgery, Beilinson Medical Center, Tel Aviv University, Israel.
Hader
T
T
Feinmesser
R
R
Har-El
G
G
Martin
D
D
Marshak
G
G
Segal
K
K
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000628:therapy; D009367:Neoplasm Staging; D016879:Salvage Therapy; D016019:Survival Analysis; D016896:Treatment Outcome